141 related articles for article (PubMed ID: 18491374)
1. Acute lymphoblastic leukemia and cutaneous mastocytosis in two children.
Masserot C; Adjaoud D; Haouy S; Deswarte C; Ballerini P; Landman-Parker J
Pediatr Blood Cancer; 2008 Sep; 51(3):444-5. PubMed ID: 18491374
[No Abstract] [Full Text] [Related]
2. [Cutaneous mastocytosis].
Flageul B
Rev Prat; 2006 Oct; 56(16):1745-51. PubMed ID: 17315498
[TBL] [Abstract][Full Text] [Related]
3. C-kit Asp-816-Val mutation analysis in patients with mastocytosis.
Verzijl A; Heide R; Oranje AP; van Schaik RH
Dermatology; 2007; 214(1):15-20. PubMed ID: 17191042
[TBL] [Abstract][Full Text] [Related]
4. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
[TBL] [Abstract][Full Text] [Related]
5. Nodular mastocytosis.
Kasprowicz S; Chan IJ; Wall DJ; Tharp MD
J Am Acad Dermatol; 2006 Aug; 55(2):347-9. PubMed ID: 16844528
[TBL] [Abstract][Full Text] [Related]
6. Tiling resolution array-based comparative genomic hybridisation analyses of acute lymphoblastic leukaemias in children with Down syndrome reveal recurrent gain of 8q and deletions of 7p and 9p.
Lundin C; Davidsson J; Hjorth L; Behrendtz M; Johansson B
Br J Haematol; 2009 Jun; 146(1):113-5. PubMed ID: 19344409
[No Abstract] [Full Text] [Related]
7. Novel R634W c-kit mutation identified in familial mastocytosis.
Pollard WL; Beachkofsky TM; Kobayashi TT
Pediatr Dermatol; 2015; 32(2):267-70. PubMed ID: 25243845
[TBL] [Abstract][Full Text] [Related]
8. N822K c-kit mutation in CD30-positive cutaneous pleomorphic mastocytosis after germ cell tumour of the ovary.
Baek JO; Kang HK; Na SY; Lee JR; Roh JY; Lee JH; Kim HJ; Park S
Br J Dermatol; 2012 Jun; 166(6):1370-3. PubMed ID: 22233328
[No Abstract] [Full Text] [Related]
9. Mastocytosis in children is associated with mutations in c-KIT.
Price CJ; Green J; Kirsner RS
J Invest Dermatol; 2010 Mar; 130(3):639. PubMed ID: 20145638
[No Abstract] [Full Text] [Related]
10. Pediatric cutaneous mastocytosis and
Ertugrul A; Bostanci I; Ozturk Kaymak A; Gurkan A; Ozmen S
Allergy Asthma Proc; 2019 Mar; 40(2):123-128. PubMed ID: 30819282
[No Abstract] [Full Text] [Related]
11. [Severe bone changes in acute lymphoblastic leukemia of children].
Zareba A; Tarnowska A; Skwarska E
Pediatr Pol; 1988 Dec; 63(12):792-7. PubMed ID: 3267803
[No Abstract] [Full Text] [Related]
12. [Acute lymphoblastic leukemia (adults and children). Diagnosis, course].
Thomas X; Thiebaut A; Fière D
Rev Prat; 1997 Dec; 47(20):2297-304. PubMed ID: 9616921
[No Abstract] [Full Text] [Related]
13. Ph+ acute lymphoblastic leukemia after iodine-131 treatment for thyroid cancer.
Piccirillo N; Sorà F; Laurenti L; Sica S; Chiusolo P; Leone G
Haematologica; 1999 Nov; 84(11):1050-1. PubMed ID: 10553170
[No Abstract] [Full Text] [Related]
14. Non-pigmented micromastocytomas: an exceptional presentation of cutaneous mastocytosis in an adult.
Autier J; Buffet M; De Maricourt S; Gorin I; Carlotti A; Dupin N
Dermatology; 2005; 211(4):376-8. PubMed ID: 16286754
[No Abstract] [Full Text] [Related]
15. CD1a-positive familial cutaneous mastocytosis without germ-line or somatic mutations in c-kit.
Arase N; Wataya-Kaneda M; Oiso N; Arase H; Katayama I
Br J Dermatol; 2013 Jul; 169(1):201-4. PubMed ID: 23834123
[No Abstract] [Full Text] [Related]
16. [Persistent acquired vascular lesions of the thigh in an infant].
Brenaut E; Fleuret C; Le Duigou D; Staroz F; Kupfer I; Plantin P
Ann Dermatol Venereol; 2010 May; 137(5):427-8. PubMed ID: 20470932
[No Abstract] [Full Text] [Related]
17. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
19. Eruptive juvenile xanthogranuloma associated with relapsing acute lymphoblastic leukemia.
Aparicio G; Mollet J; Bartralot R; Bodet D; Heras C; Bassas P; Virós A; García-Patos V
Pediatr Dermatol; 2008; 25(4):487-8. PubMed ID: 18789100
[TBL] [Abstract][Full Text] [Related]
20. Management of brain abscesses in children treated for acute lymphoblastic leukemia.
Lackner H; Sovinz P; Benesch M; Smolle-Jüttner F; Mokry M; Schwinger W; Moser A; Urban C
Pediatr Blood Cancer; 2009 Mar; 52(3):408-11. PubMed ID: 18989879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
